Tyra Biosciences, Inc.
TYRA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$133M | −$104M | −27.4% |
| Net income | −$120M | −$86.5M | −38.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$54.9M | −$32.9M | −66.9% |
| Net income | −$51.1M | −$29.9M | −70.9% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Tyra Biosciences's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
- Was Tyra Biosciences profitable in FY2025?
- No: net income was −$120M and operating income −$133M in FY2025.
- What was Tyra Biosciences's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 10, 2026.